Page last updated: 2024-09-03

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and n-methyladenosine

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with n-methyladenosine in 1 studies

Compound Research Comparison

Studies
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
Trials
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
Recent Studies (post-2010)
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
Studies
(n-methyladenosine)
Trials
(n-methyladenosine)
Recent Studies (post-2010) (n-methyladenosine)
2145581,47031,400

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duong, HT; Gao, ZG; Jacobson, KA; Joshi, BV; Kim, SK; Tchilibon, S1

Other Studies

1 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and n-methyladenosine

ArticleYear
(N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.
    Journal of medicinal chemistry, 2005, Mar-24, Volume: 48, Issue:6

    Topics: Adenine; Adenosine A3 Receptor Agonists; Animals; Binding Sites; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Humans; Models, Molecular; Nucleosides; Radioligand Assay; Rats; Receptor, Adenosine A3; Stereoisomerism; Structure-Activity Relationship

2005